- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/62 - Benzothiazoles
Détention brevets de la classe C07D 277/62
Brevets de cette classe: 255
Historique des publications depuis 10 ans
|
9
|
20
|
13
|
14
|
9
|
7
|
14
|
16
|
14
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Shanghai Kechow Pharma Inc. | 22 |
8 |
| Sumitomo Chemical Company, Limited | 9015 |
6 |
| Takeda Pharmaceutical Company Limited | 2718 |
6 |
| The Wistar Institute of Anatomy and Biology | 474 |
5 |
| The Regents of the University of California | 20590 |
4 |
| Boehringer Ingelheim International GmbH | 4494 |
4 |
| Actelion Pharmaceuticals Ltd | 500 |
4 |
| Fuji Yakuhin Co., Ltd. | 11 |
4 |
| Gilead Sciences, Inc. | 2207 |
4 |
| Merck Canada Inc. | 81 |
4 |
| Nanoquantum Sciences, Inc. | 6 |
4 |
| Vectus Biosystems Limited | 28 |
4 |
| Bayer Cropscience AG | 1878 |
3 |
| FUJIFILM Corporation | 30327 |
3 |
| Abbvie Inc. | 1837 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2645 |
3 |
| DIC Corporation | 3924 |
3 |
| Forma Therapeutics, Inc. | 147 |
3 |
| Rutgers, The State University of New Jersey | 1959 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
3 |
| Autres propriétaires | 174 |